酵素结合免疫吸附检测法(ELISA) 检测市场报告：2031 年趋势、预测与竞争分析

全球酵素结合免疫吸附检测法(ELISA) 检测市场前景光明，医院和诊断中心、製药和生物技术公司、学术研究中心和临床实验室市场都存在机会。全球酵素结合免疫吸附检测法(ELISA) 市场预计在 2025 年至 2031 年期间的复合年增长率为 7.5%。该市场的主要驱动力是爱滋病毒、登革热、肝炎、疟疾和流感等感染疾病的日益流行，以及面临多种感染疾病风险的老年人口的不断增加。

• 根据类型，Lucintel 预测，多功能可携式ELISA 将在预测期内见证最高成长，因为它具有便携性和持续的技术进步。
• 在最终用途类别中，由于疾病盛行率不断上升、个人化医疗需求不断增长以及政府对 ELISA 检测的支持不断增加，预计医院和诊断中心将继续成为最大的细分市场。
• 从地区来看，由于老龄人口的快速增长、医疗设备的采用率不断提高以及先进的医疗保健基础设施的存在，预计北美将在预测期内继续成为最大的地区。

酵素结合免疫吸附检测法（ELISA）市场的策略性成长机会

ELISA 检测市场为各种应用提供了多种策略成长机会。

• 疾病诊断：ELISA 检测在诊断新兴感染疾病的应用日益广泛，因其能够及时、特异性识别，因此具有巨大的成长潜力。
• 药物开发研究：药物开发研究：ELISA 测试在药物开发中的应用日益广泛，特别是在药物动力学监测和治疗标靶检验方面，这代表着医学领域的宝贵机会。
• 环境监测：受监管压力和环境问题的推动，ELISA 在环境污染物和毒素监测中的应用正在增加。
• 食品安全：随着食品安全法规和消费者意识的不断提高，ELISA 在食品检测中检测污染物和过敏原变得越来越重要。
• 临床研究：ELISA 在生物标记的发现和检验中发挥关键作用，支持个人化医疗和标靶治疗，从而开闢新的市场能力。

这些领域中 ELISA 的使用日益广泛，推动着市场的成长。

酵素结合免疫吸附检测法（ELISA）检测市场驱动因素与挑战

影响 ELISA 检测市场的因素有很多，包括技术、经济和监管。我们在此分析关键驱动因素与挑战

推动酵素结合免疫吸附检测法（ELISA）市场发展的因素如下：

• 技术进步：新型 ELISA 技术的发明和发展、自动化、灵敏度的提高等提高了测试的产量和准确性，从而推动了市场的发展。
• 疾病盛行率不断上升：慢性病和感染疾病的盛行率不断上升。这使得对有效、可靠的诊断工具（包括 ELISA 测试）的需求日益增长。
• 政府措施：政府的优惠政策以及对研究和医疗基础设施的投资正在加强 ELISA 市场。
• 提高意识：人们对疾病早期诊断和个人化医疗的认识不断提高，推动了 ELISA 测试的采用。
• 不断增加的应用：包括临床诊断和监测在内的更广泛的应用正在创造新的市场机会。

酵素结合免疫吸附检测法（ELISA）检测市场挑战：

• 成本高：先进的 ELISA 系统和试剂的成本可能会限制其在资源匮乏的环境中的应用。
• 监管障碍：对 ELISA 测试的核准和验证的严格监管要求可能会延迟市场进入并增加开发成本。

这些市场驱动因素和挑战正在塑造 ELISA 市场并影响相关人员的策略决策。

目录

第一章执行摘要

第二章全球酵素免疫分析法（ELISA）检测市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球酵素免疫分析法试验 (ELISA) 检测市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球酵素免疫分析法试验（ELISA）检测市场类型
  • 夹心 ELISA
  • 间接 ELISA
  • 多功能可携式ELISA
  • 竞争性 ELISA
• 全球酵素免疫分析法试验（ELISA）检测市场（依应用）
  • 免疫学
  • 疫苗研发
  • 感染疾病
  • 癌症
  • 蛋白质定量
  • 其他的
• 全球酵素免疫分析法试验（ELISA）检测市场（依最终用途）
  • 医院和诊断中心
  • 製药和生物技术公司
  • 学术研究中心
  • 临床实验室
  • 其他的

第四章2019年至2031年区域市场趋势与预测分析

• 区域酵素免疫分析法试验（ELISA）检测市场
• 北美酵素免疫分析法试验（ELISA）检测市场
• 欧洲酵素免疫分析法试验（ELISA）检测市场
• 亚太地区酵素免疫分析法试验（ELISA）检测市场
• 世界其他地区的酵素免疫分析法试验（ELISA）检测市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球酵素免疫分析法试验（ELISA）检测市场成长机会（按类型）
  • 全球酵素免疫分析法试验（ELISA）检测市场的成长机会（按应用）
  • 全球酵素免疫分析法试验（ELISA）检测市场的成长机会（依最终用途划分）
  • 区域酵素免疫分析法试验（ELISA）检测市场的成长机会
• 全球酵素免疫分析法（ELISA）检测市场的新趋势
• 战略分析
  • 新产品开发
  • 全球酵素免疫分析法（ELISA）检测市场的产能扩张
  • 全球酵素免疫分析法(ELISA) 检测市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others, and the growing geriatric population who are at risk of developing several infections.

• Lucintel forecasts that, within the type category, multiple and portable ELISA is expected to witness the highest growth over the forecast period due to portability and on-going technological advancements.
• Within the end use category, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.
• In terms of regions, North America will remain the largest region over the forecast period due to a surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market is shaped by several key trends:

• High-Throughput Screening: Automation enables laboratories to adopt high-throughput screening, significantly speeding up sample processing and reducing turnaround times, thus enhancing productivity.
• Multiplex ELISA: The development of multiplex ELISA tests allows for the simultaneous detection of multiple targets, improving diagnostic accuracy and streamlining workflows by reducing the need for multiple tests.
• Integration with Digital Platforms: Increasing integration of ELISA systems with digital platforms for data management and analysis enhances result precision and reproducibility through advanced software solutions.
• Point-of-Care Testing (POCT): There is growing interest in portable and user-friendly ELISA devices for POCT, providing timely diagnostics, especially in remote or underserved areas.
• Personalized Medicine: ELISA technologies are being adapted for personalized medicine, enabling tailored diagnostic and therapeutic strategies based on individual patient profiles and genetic information.

These trends contribute to the efficiency, accuracy, and accessibility of ELISA tests, driving innovation across various healthcare and research applications.

Recent Developments in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Technological innovations and the rising demand for accurate diagnoses are propelling growth in the ELISA test market. Key developments include:

• Automation Integration: Automated ELISA systems are transforming laboratory operations by increasing sample throughput and reducing human error, resulting in more consistent and reliable performance.
• Improved Sensitivity: Advancements in ELISA technology have significantly enhanced assay sensitivity, enabling the detection of low analyte levels and facilitating early disease diagnosis.
• Portable ELISA Devices: The emergence of portable ELISA devices expands testing capabilities beyond laboratories, allowing for seamless testing in remote or resource-limited settings.
• Customizable ELISA Kits: The market is seeing more customizable ELISA kits designed for specific research or disease targets, providing greater flexibility and precision in diagnostics.
• Sustainable Practices: Manufacturers are increasingly focusing on sustainable practices, aiming to reduce waste and use eco-friendly materials in the production of ELISA kits and reagents.

These advancements are enhancing diagnostic capabilities and expanding the scope of ELISA tests.

Strategic Growth Opportunities for Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA tests market offers several strategic growth opportunities across various applications:

• Disease Diagnostics: Expanding the use of ELISA for diagnosing emerging and infectious diseases presents significant growth potential for timely and specific identification.
• Drug Development Studies: ELISA tests are increasingly utilized in drug development, particularly for monitoring pharmacokinetics and validating therapeutic targets, presenting a valuable opportunity in pharmaceuticals.
• Environmental Monitoring: ELISA applications in environmental monitoring for pollutants and toxins are growing, driven by regulatory pressures and environmental concerns.
• Food Safety: ELISA is becoming essential in food testing to detect contaminants and allergens, spurred by increasing food safety regulations and consumer awareness.
• Clinical Research: ELISA plays a critical role in biomarker discovery and validation, supporting personalized medicine and targeted therapies, thus opening new market capabilities.

The expansion of ELISA applications across these sectors is fueling market growth.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Driver and Challenges

Factors influencing the ELISA tests market range from technological, and economic, to regulatory. Here is an analysis of some of the important drivers and challenges:

The factors responsible for driving the enzyme-linked immunosorbent assay (ELISA) tests market include:

• Technological Advancements: Invention and development of new ELISA technologies instance, automation and improved sensitivity-have raised the output and precision of the tests, hence driving market growth.
• Increased Disease Prevalence: There is now a greater incidence of chronic and infectious diseases. This, in turn, is driving demand for effective and reliable diagnostic tools, which include ELISA tests.
• Government Initiatives: Favorable government policies and investments in research and health infrastructure enhance the ELISA market.
• Rising Awareness: Growing awareness of early disease diagnosis and personalized medicine promotes increased adoption of ELISA tests.
• Increasing Applications: The broadening range of applications, including clinical diagnostics and monitoring, creates new market opportunities.

Challenges in the enzyme-linked immunosorbent assay (ELISA) tests market are:

• High Costs: The cost of advanced ELISA systems and reagents may limit their accessibility in resource-poor settings.
• Regulatory Hurdles: Stringent regulatory requirements for the approval and validation of ELISA tests can delay market entry and increase development costs.

These drivers and challenges are shaping the ELISA market and influencing strategic decisions among stakeholders.

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

• Ortho Clinical Diagnostics
• Thermos Fisher Scientific
• BioMerieux
• Sysmex Corporation
• F. Hoffmann-La Roche
• Danaher Corporation
• Quidel Corporation
• Bio-Rad Laboratories
• Siemens Healthineers
• Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests market by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Analysis by Value from 2019 to 2031]:

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA
• Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Analysis by Value from 2019 to 2031]:

• Immunology
• Vaccine Development
• Infectious diseases
• Cancer
• Protein quantitation
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals and Diagnostic Centers
• Pharmaceutical and Biotech Companies
• Academic Research Centers
• Clinical Laboratories
• Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

The ELISA test market is rapidly evolving with technological advancements and growing diagnostic demands. Recent developments in key markets include:

• United States: Innovation is thriving, with various high-throughput ELISA systems enhancing efficiency and accuracy to meet diagnostic and research demands.
• China: There is a focus on developing low-cost ELISA tests to improve accessibility in both urban and rural areas, supported by government initiatives to strengthen public health infrastructure.
• Germany: Companies are incorporating automation and digitalization into ELISA technology, maximizing laboratory workflow benefits for diagnostics and research.
• India: The increasing manufacturing of ELISA kits in India is reducing reliance on imports, enhancing the cost-effectiveness and accessibility of diagnostic tools.
• Japan: Japan is leading in developing multiplex ELISA tests, capable of detecting multiple analytes simultaneously, thus improving disease detection and monitoring efficiency.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by various segments, such as by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 3.3.1: Sandwich ELISA
  • 3.3.2: Indirect ELISA
  • 3.3.3: Multiple and portable ELISA
  • 3.3.4: Competitive ELISA
• 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 3.4.1: Immunology
  • 3.4.2: Vaccine Development
  • 3.4.3: Infectious diseases
  • 3.4.4: Cancer
  • 3.4.5: Protein quantitation
  • 3.4.6: Others
• 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 3.5.1: Hospitals and Diagnostic Centers
  • 3.5.2: Pharmaceutical and Biotech Companies
  • 3.5.3: Academic Research Centers
  • 3.5.4: Clinical Laboratories
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.2.1: North American Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.2.2: North American Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.3.1: European Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.3.2: European Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.4.1: APAC Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.4.2: APAC Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
• 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 4.5.1: ROW Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
  • 4.5.2: ROW Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
  • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
  • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
  • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
• 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ortho Clinical Diagnostics
• 7.2: Thermos Fisher Scientific
• 7.3: BioMerieux
• 7.4: Sysmex Corporation
• 7.5: F. Hoffmann-La Roche
• 7.6: Danaher Corporation
• 7.7: Quidel Corporation
• 7.8: Bio-Rad Laboratories
• 7.9: Siemens Healthineers
• 7.10: Abbott Laboratories